|
GAINESVILLE, FL / ACCESSWIRE / June 12, 2023 / Neobiosis, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of medicines. Today, Neobiosis announced that the U.S. Food and Drug Administration FDA has approved the Investigational New Drug IND application for ViXome™, its drug for the... Lire le communiqué |
